A carregar...
TFH lymphomas: the times they aza-changin’?
In this issue of Blood, O’Connor and colleagues(1) report a phase 1 study of romidepsin combined with oral azacytidine in patients with relapsed/refractory (R/R) lymphomas, including complete remissions among 3 patients with angioimmunoblastic T-cell lymphoma (AITL) and single patients with multiple...
Na minha lista:
| Publicado no: | Blood |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6839955/ https://ncbi.nlm.nih.gov/pubmed/31698426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019002806 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|